Drug Research

In Hong Kong, lung cancer continues to be the most prevalent form of cancer. Despite its status as a prominent global cause of cancer-related deaths, there is still a need for a significant breakthrough in its treatment. The Faculty...

Telix Pharmaceuticals Limited opened Telix Manufacturing Solutions, the company's radiopharmaceutical production facility located in Belgium. The 2,800 square meter facility is one of Europe's largest radiopharmaceutical production facilities, according to the company. It will serve as Telix’s primary manufacturing site...

Charles River Laboratories International, Inc. and the INADcure Foundation, a nonprofit organization whose mission is to support the development of treatments for Infantile Neuroaxonal Dystrophy (INAD) and other forms of PLA2G6-related neurodegeneration (PLAN), today announced a plasmid DNA manufacturing...

Quell Therapeutics Ltd, a leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, announced that it has entered into a collaboration, exclusive option and license agreement with AstraZeneca to develop, manufacture...

It is well to be noted that pharma and biotech companies splurged a whopping $85 billion in the first five months of 2023, which itself went on to mark a dramatic recovery when it comes to dealmaking as they...

Samsung Biologics and Pfizer announced a strategic partnership for the long-term commercial manufacturing of Pfizer’s multi-product portfolio. Samsung Biologics and Pfizer entered into an initial manufacturing agreement in March 2023 for a Pfizer product. Under the terms of the new...

Scientists at Tohoku University in Japan have made a significant discovery in the field of cancer treatment. They have found a new approach to enhance the efficacy of immune checkpoint blockade (ICB), a type of cancer therapy that uses...